[Intravenous fat emulsion: lipid therapy as a new antidote].
Mariko
M
Fukumoto
D000319:Adrenergic beta-Antagonists / Q000506:poisoning; D000779:Anesthetics, Local / Q000506:poisoning*; D000929:Antidepressive Agents, Tricyclic / Q000506:poisoning; D000931:Antidotes / Q000008:administration & dosage; D002118:Calcium / Q000378:metabolism; D004734:Energy Metabolism; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage / Q000494:pharmacology; D006323:Heart Arrest / Q000139:chemically induced*; D006801:Humans; D008929:Mitochondria, Heart / Q000378:metabolism; D009200:Myocardial Contraction; D009206:Myocardium / Q000378:metabolism; D017410:Practice Guidelines as Topic; D017180:Tachycardia, Ventricular / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists; D000779:Anesthetics, Local; D000929:Antidepressive Agents, Tricyclic; D000931:Antidotes; D005217:Fat Emulsions, Intravenous; D002118:Calcium